Health
The US FDA has approved AstraZeneca’s Tagrisso and chemotherapy combination
AstraZeneca’s combination of AstraZeneca’s blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung cancer has been approved by the US Food and
US FDA approved for Iovance skin cancer cell therapy
Iovance Biotherapeutics the US health regulator has granted accelerated approval for a cell therapy for adult patients with advanced melanoma, the first such treatment approved
US FDA to review Sarepta’s Duchenne gene therapy for traditional approval
Sarepta Therapeutics said the US FDA will review the application for traditional approval of its gene therapy to treat the muscle atrophy disorder by 21
GSK has completed the acquisition of Aiolos Bio for $1.4bn
GSK said Thursday it has completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company specialising in respiratory and inflammatory diseases. GSK will pay $1
US FDA approves first treatment for severe frostbite
The US Food and Drug Administration on Wednesday approved Eicos Sciences’ injection, making it the first-ever treatment for severe frostbite in adults. The drug, which
Cancer testing company Freenome raises $254m in new funding
Blood test developer Freenome said Thursday it has raised $254 million in a new round of funding led by Swiss drugmaker Roche to develop tests
Cholera vaccine stocks ’empty’ due to rising incidence of disease
The emergency global stockpile of cholera vaccine is empty and all available doses for this month have already been distributed to countries battling major outbreaks,
U.S. has ‘about 18 months’ to create bird flu vaccine
The U.S. Department of Agriculture has “about 18 months” to create a vaccine for the current strain of bird flu and develop a process for
Britain sees the launch of weight loss drug Lilly Mounjaro
Eli Lilly’s Munjaro will be launched in the UK this week, two pharmacy companies said on Wednesday, making the UK the fourth European country to
Pharmaceutical group’s lawsuit over Medicare drug pricing programme dismissed
A federal judge on Monday dismissed a lawsuit by a major pharmaceutical industry trade association challenging a new programme that allows Medicare to negotiate prices